Skip to content
FDAMedical devices

Olympus Expands Voluntary Recall for ViziShot 2 FLEX (19G) EBUS -TBNA Needles

FDA recall n-olympus-expands-voluntary-recall-vizishot-2-flex-19g-ebus-tbna-needles ·

Build snapshot. Collected , once, when this site was built. It is not a live feed.

What the agency says to do

FDA’s record gives no instruction for consumers.

Note from Recalls Watch, not agency text

Why it was recalled

Device & Drug Safety - Defect
Text from FDA, unedited.

The recalled product

CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching during
Text from FDA, unedited.

Company announcement, as FDA publishes it

CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching during procedures. The complaints included adverse event reports of patient injury and one death. This expanded action includes all lots of the ViziShot 2 FLEX needles and supersedes the August 2025 notice in which only certain lots of the device were being recalled.

Potential consequences of a detached component of the ViziShot 2 FLEX include the risk of unintended device components within the tracheobronchial tree that may require bronchoscopic extraction or surgical removal.

Since the August 2025 notice, internal investigations of complaints identified additional contributing factors to hypotube component ejection including device heat-shrink material degradation and use errors, which affect all lots of the ViziShot 2 FLEX device. The device heat-shrink material that seals the needle can degrade during clinical use and may result in difficulty in extracting or expelling samples, fluid leakage, impaired needle deployment or retraction, or breakage of device components.

Users are directed to cease use immediately and quarantine all ViziShot 2 FLEX devices. Customers have been instructed to return the affected devices to Olympus by following the instructions provided in the removal action communication. Patient safety is our top priority.

The ViziShot 2 FLEX is designed to be used with ultrasound endoscopes for ultrasound guided fine needle aspiration and fine needle biopsy of submucosal and extramural lesions of the tracheobronchial tree.

Other EBUS-TBNA needles are not affected by this action.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch program online: https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program/reporting-serious-problems-fda .

For information on how to identify affected product, U.S. customers can contact the Olympus Technical Assistance Center (TAC) at 1-800-848-9024, Option 1, Monday-Friday between 7:00 AM and 8:00 PM ET. U.S. customers can report a problem with the device to TAC by phone, or by email at complaints@olympus.com .

For information on how to identify affected product, U.S. customers can contact the Olympus Technical Assistance Center (TAC) at 1-800-848-9024, Option 1, Monday-Friday between 7:00 AM and 8:00 PM ET. U.S. customers can report a problem with the device to TAC by phone, or by email at complaints@olympus.com .

Link to Original Press Release

Text from FDA (the company’s words), unedited.
  • Olympus ViziShot 2 FLEX (19G) EBUS -TBNA needles

Source

Issued by
U.S. Food and Drug Administration
Firm
Olympus Corporation

Check all notices that name this firm in the directory of recalls by brand and manufacturer. This notice is in these lists: Firm: Olympus Corporation, Month: January 2026, Week 2026-W03. Browse more medical devices recalls, or check another notice by its number in the recall number lookup.

About this recall

What is the hazard?

FDA states: “Device & Drug Safety - Defect”

What should I do if I have this product?

FDA’s record gives no instruction for consumers. The official report is linked on this page.

Which products are included?

FDA states: “CENTER VALLEY, Pa., (January 16, 2026) — Olympus Corporation has announced the expansion of a previous global medical device removal action for ViziShot 2 FLEX (19G) EBUS -TBNA needles (“ViziShot 2 FLEX”) after receiving and investigating complaints of device components ejecting or detaching during”

When was this recall published?

FDA published this company announcement on January 16, 2026.

Other notices of Olympus Corporation